Literature DB >> 30054012

Genome-wide analyses and functional profiling of human NK cell lines.

Justin T Gunesch1, Laura S Angelo2, Sanjana Mahapatra1, Raquel P Deering3, Johanna E Kowalko3, Patrick Sleiman3, John W Tobias4, Linda Monaco-Shawver3, Jordan S Orange5, Emily M Mace6.   

Abstract

Natural killer (NK) cell lines, including YTS, NK92, NK3.3, and NKL, represent excellent models for the study of human natural killer cells. While phenotypic and functional differences between these cell lines have been reported, a multi-parametric study, encompassing genomic, phenotypic, and functional assays, has not been performed. Here, using a combination of techniques including microarray and copy number analyses, flow cytometry, and functional assays, we provide in-depth genetic, functional, and phenotypic comparison of YTS, NK92, NK3.3, and NKL cell lines. Specifically, we found that while the cell lines shared similarities in enrichment of growth and survival pathways, they had differential expression of 557 genes, including genes related to NK cell development, survival, and function. In addition, we provide genetic and phenotypic analyses that demonstrate distinct developmental origins of NK92, YTS, and NKL cell lines. Specifically, NK92 has a phenotype associated with the CD56bright NK cell subset, while both YTS and NKL appear more CD56dim-like. Finally, by classifying cell lines based on their lytic potential, we identified genes differentially expressed between NK cell lines with high and low lytic function. Taken together, these data provide the first comprehensive genetic, phenotypic, and functional analyses of these commonly used NK cell lines and provides deeper understanding into their origins and function. This will ultimately improve their use as models for human NK cell biology.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD56; Cell line; Cytotoxicity; NK cell; NK cell phenotype

Mesh:

Substances:

Year:  2018        PMID: 30054012      PMCID: PMC6345623          DOI: 10.1016/j.molimm.2018.07.015

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  56 in total

1.  Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation.

Authors:  Andrea De Maria; Federica Bozzano; Claudia Cantoni; Lorenzo Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Biallelic mutations in IRF8 impair human NK cell maturation and function.

Authors:  Emily M Mace; Venetia Bigley; Justin T Gunesch; Ivan K Chinn; Laura S Angelo; Matthew A Care; Sheetal Maisuria; Michael D Keller; Sumihito Togi; Levi B Watkin; David F LaRosa; Shalini N Jhangiani; Donna M Muzny; Asbjørg Stray-Pedersen; Zeynep Coban Akdemir; Jansen B Smith; Mayra Hernández-Sanabria; Duy T Le; Graham D Hogg; Tram N Cao; Aharon G Freud; Eva P Szymanski; Sinisa Savic; Matthew Collin; Andrew J Cant; Richard A Gibbs; Steven M Holland; Michael A Caligiuri; Keiko Ozato; Silke Paust; Gina M Doody; James R Lupski; Jordan S Orange
Journal:  J Clin Invest       Date:  2016-11-28       Impact factor: 14.808

3.  Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56).

Authors:  L L Lanier; C Chang; M Azuma; J J Ruitenberg; J J Hemperly; J H Phillips
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

4.  Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.

Authors:  Bartosz Grzywacz; Nandini Kataria; Magdalena Sikora; Robert A Oostendorp; Elaine A Dzierzak; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

Review 5.  Human natural killer cell development.

Authors:  Aharon G Freud; Michael A Caligiuri
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

6.  Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity.

Authors:  Jennifer T Grier; Lisa R Forbes; Linda Monaco-Shawver; Jennifer Oshinsky; T Prescott Atkinson; Curtis Moody; Rahul Pandey; Kerry S Campbell; Jordan S Orange
Journal:  J Clin Invest       Date:  2012-09-24       Impact factor: 14.808

7.  Kinetics of cellular cytotoxicity mediated by a cloned human natural killer cell line.

Authors:  N H Mahle; G Radcliff; C L Sevilla; J Kornbluth; D M Callewaert
Journal:  Immunobiology       Date:  1989-06       Impact factor: 3.144

8.  MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans.

Authors:  Claire R Hughes; Leonardo Guasti; Eirini Meimaridou; Chen-Hua Chuang; John C Schimenti; Peter J King; Colm Costigan; Adrian J L Clark; Louise A Metherell
Journal:  J Clin Invest       Date:  2012-02-22       Impact factor: 14.808

9.  Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells.

Authors:  Yenan T Bryceson; Michael E March; Domingo F Barber; Hans-Gustaf Ljunggren; Eric O Long
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

10.  Human NK cell development requires CD56-mediated motility and formation of the developmental synapse.

Authors:  Emily M Mace; Justin T Gunesch; Amera Dixon; Jordan S Orange
Journal:  Nat Commun       Date:  2016-07-20       Impact factor: 14.919

View more
  17 in total

1.  Fatty acids promote the expansion of NK-92 cells in vitro by improving energy metabolism.

Authors:  Zhepei Xie; Yan Fu; Wen-Song Tan; Haibo Cai
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-15       Impact factor: 4.813

2.  Differential modulation of natural killer cell cytotoxicity by 17β-estradiol and prolactin through the NKG2D/NKG2DL axis in cervical cancer cells.

Authors:  Alejandro Godoy-Pacheco; Mariel García-Chagollán; Adrián Ramírez-De-Arellano; Christian David Hernández-Silva; Julio César Villegas-Pineda; Inocencia Guadalupe Ramírez-López; José Sergio Zepeda-Nuño; Adriana Aguilar-Lemarroy; Ana Laura Pereira-Suárez
Journal:  Oncol Lett       Date:  2022-06-28       Impact factor: 3.111

Review 3.  A research-driven approach to the identification of novel natural killer cell deficiencies affecting cytotoxic function.

Authors:  Michael T Lam; Emily M Mace; Jordan S Orange
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

Review 4.  Humanized Mouse Models for the Advancement of Innate Lymphoid Cell-Based Cancer Immunotherapies.

Authors:  Nina B Horowitz; Imran Mohammad; Uriel Y Moreno-Nieves; Ievgen Koliesnik; Quan Tran; John B Sunwoo
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

5.  Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy.

Authors:  Hyun Gul Yang; Moon Cheol Kang; Tae Yoon Kim; Injung Hwang; Hyun Tak Jin; Young Chul Sung; Ki-Seong Eom; Sae Won Kim
Journal:  J Immunother Cancer       Date:  2019-05-24       Impact factor: 13.751

6.  A novel endogenous CD16-Expressing Natural Killer Cell for cancer immunotherapy.

Authors:  Zih-Fei Cheng; Hao-Kang Li; Hsiu-Ping Yang; Chia-Yun Lee; Sai-Wen Tang; Yan-Liang Lin; Shih-Chia Hsiao
Journal:  Biochem Biophys Rep       Date:  2021-02-03

Review 7.  Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.

Authors:  Natasha Mupeta Kaweme; Fuling Zhou
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

8.  CD56 regulates human NK cell cytotoxicity through Pyk2.

Authors:  Justin T Gunesch; Amera L Dixon; Tasneem Am Ebrahim; Melissa M Berrien-Elliott; Swetha Tatineni; Tejas Kumar; Everardo Hegewisch-Solloa; Todd A Fehniger; Emily M Mace
Journal:  Elife       Date:  2020-06-08       Impact factor: 8.140

Review 9.  TRP Channels as Interior Designers: Remodeling the Endolysosomal Compartment in Natural Killer Cells.

Authors:  Dennis Clement; Jodie P Goodridge; Christian Grimm; Sandip Patel; Karl-Johan Malmberg
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

10.  Augmentation of NK Cell Proliferation and Anti-tumor Immunity by Transgenic Expression of Receptors for EPO or TPO.

Authors:  Chantiya Chanswangphuwana; David S J Allan; Mala Chakraborty; Robert N Reger; Richard W Childs
Journal:  Mol Ther       Date:  2020-09-20       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.